Business · 13/09/2022Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Withdrawal of 31 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is correcting a notice that announced the withdrawal of approval of 31 abbreviated new drug applications (ANDAs) from multiple applicants, including USpharma Windlas, LLC, due to a request not to withdraw the approvals of two specific ANDAs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →